EpiPen auto-injection epinephrine pens manufactured by Mylan NV pharmaceutical company for use by severe allergy sufferers are seen in Washington, U.S. August 24, 2016. REUTERS/Jim Bourg/File Photo
1 / 30
Reuters | Photo By JIM BOURG / Reuters
Mon, Aug 29, 2016 6:28 AM EDT